Literature DB >> 28939046

Hospital-Based Study of the Frequency and Risk Factors of Stroke Recurrence in Two Years in China.

Qian He1, Cheng Wu1, Wei Guo1, Zhi-Yong Wang2, Yan-Fang Zhao1, Jian Lu1, Ying-Yi Qin1, Yi-Bin Guo1, Yu-Chen Qin1, Chuan-Di Pan3, Jia He4.   

Abstract

BACKGROUND: Stroke causes death and disability throughout the world and recurrent stroke events are more likely to be disabling or fatal. We conducted a hospital-based study to investigate the frequency and influence factors of stroke recurrence in China.
METHODS: Data from patients hospitalized with stroke between January 2007 and December 2010 of 109 tertiary hospitals in China were used. Stroke recurrence and associated factors were ascertained. The zero-inflated model was used to evaluate the factors of recurrence.
RESULTS: Of 101,926 discharged patients, the cumulative 2-year stroke recurrence rate was 3.80% for subarachnoid hemorrhage (SAH), 5.31% for intracerebral hemorrhage (ICH), and 8.71% for ischemic stroke (IS), respectively. Among patients with stroke recurrence, 54.11% with SAH, 60.42% with ICH, and 92.92% with IS relapsed for the same type of the first-onset stroke. For discharged patients with SAH with middle cerebral artery aneurysm clipping or artery aneurysm embolization, it was less likely to stroke relapse, but the times of recurrence would increase if 1 recurrence appeared. Cerebral artery aneurysms and hypertension were risk factors for recurrence frequency. For ICH, protective factors for recurrence were trepanation and drainage of intracranial hematoma, cerebral angiography, puncture and drainage of intracranial hematoma, and length of stay (LOS). But rheumatic heart disease and atrial fibrillation would further the relapse frequency. For IS, age and LOS were protective factors, but recurrence frequency would increase if the first recurrence happened. Cervical spondylopathy, male gender, and diabetes were risk factors for frequency of relapse.
CONCLUSIONS: Associated factors were different for recurrence frequency among different stroke types.
Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Stroke recurrence; intracerebral hemorrhage; ischemic stroke; subarachnoid hemorrhage; zero-inflated model

Mesh:

Year:  2017        PMID: 28939046     DOI: 10.1016/j.jstrokecerebrovasdis.2017.05.026

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  7 in total

1.  Sex Differences in Intracranial Atherosclerotic Plaques Among Patients With Ischemic Stroke.

Authors:  Xuejiao Yan; Min Tang; Jie Gao; Lihui Wang; Ling Li; Niane Ma; Xiaorui Shi; Xiaoyan Lei; Xiaoling Zhang
Journal:  Front Cardiovasc Med       Date:  2022-06-30

2.  Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy.

Authors:  Zhi-Yi Xu; Yang Xu; Xiao-Fang Xie; Yin Tian; Jun-Hui Sui; Yong Sun; Da-Sheng Lin; Xing Gao; Cheng Peng; Yu-Jiang Fan
Journal:  Chin Med       Date:  2021-01-19       Impact factor: 5.455

3.  Cumulative risk of stroke recurrence over the last 10 years: a systematic review and meta-analysis.

Authors:  Beilei Lin; Zhenxiang Zhang; Yongxia Mei; Chongjian Wang; Hui Xu; Lamei Liu; Wenna Wang
Journal:  Neurol Sci       Date:  2020-10-10       Impact factor: 3.307

4.  Level of Knowledge on Stroke and Associated Factors: A Cross-Sectional Study at Primary Health Care Centers in Morocco.

Authors:  Ahmed Kharbach; Majdouline Obtel; Abderrahmane Achbani; Youssef Bouchriti; Kenza Hassouni; Laila Lahlou; Rachid Razine
Journal:  Ann Glob Health       Date:  2020-07-23       Impact factor: 2.462

5.  Antiplatelet therapy may be safe in ischemic stroke patients with cerebral microbleed.

Authors:  Ningqin Meng; Wei Zhang; Ying Su; Ziming Ye; Chao Qin
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

6.  Comparison of In-Hospital Mortality and Length of Stay in Acute ST-Segment-Elevation Myocardial Infarction Among Urban Teaching Hospitals in China and the United States.

Authors:  Hedong Han; Xin Wei; Qian He; Yamei Yu; Yiming Ruan; Cheng Wu; Yang Cao; Eyal Herzog; Jia He
Journal:  J Am Heart Assoc       Date:  2019-11-13       Impact factor: 5.501

7.  Ginkgol Biloba extract as an adjunctive treatment for ischemic stroke: A systematic review and meta-analysis of randomized clinical trials.

Authors:  Hongjian Ji; Xiaohua Zhou; Wenlong Wei; Wenyong Wu; Shuai Yao
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.